The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb

Journal of Molecular Biology

Volumn 426, Issue 24, 2014, Pages 4030-4048

  Jansma, Ariane L ^a,b   Martinez Yamout, Maria A ^a   Liao, Rong ^a   Sun, Peiqing ^a   Dyson, H Jane ^a   Wright, Peter E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b POINT LOMA NAZARENE UNIVERSITY   (United States)

Author keywords

acetyltransferase; CBP p300; human papillomavirus; intrinsic protein disorder; NMR

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; E1A ASSOCIATED P300 PROTEIN; PROTEIN E7; PROTEIN P53; RETINOBLASTOMA PROTEIN; EP300 PROTEIN, HUMAN; MULTIPROTEIN COMPLEX; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; PROTEIN BINDING;

ACETYLATION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL ASSAY; CELL FUNCTION; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN PAPILLOMAVIRUS TYPE 16; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; AMINO ACID SEQUENCE; BINDING COMPETITION; CELL LINE; CELL TRANSFORMATION; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; FIBROBLAST; FLUORESCENCE POLARIZATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; RISK FACTOR; SEQUENCE HOMOLOGY; WESTERN BLOTTING;

HUMAN PAPILLOMAVIRUS;

AMINO ACID SEQUENCE; BINDING, COMPETITIVE; BLOTTING, WESTERN; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; E1A-ASSOCIATED P300 PROTEIN; FIBROBLASTS; FLUORESCENCE POLARIZATION; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MULTIPROTEIN COMPLEXES; MUTATION; PAPILLOMAVIRUS E7 PROTEINS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RETINOBLASTOMA PROTEIN; RISK FACTORS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84914706525     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2014.10.021     Document Type: Article

References (90)

1. E.-M. de Villiers, C. Fauquet, T.R. Broker, H.-U. Bernard, and H. zur Hausen Classification of papillomaviruses Virology 324 2004 17 27
2. H. zur Hausen Papillomavirus infections - a major cause of human cancers Biochim Biophys Acta 1288 1996 F55 F78
3. H. zur Hausen Papillomaviruses and cancer: from basic studies to clinical application Nat Rev Cancer 2 2002 342 350
4. A.J. Berk Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus Oncogene 24 2005 7673 7685
5. K. Munger, W.C. Phelps, V. Bubb, P.M. Howley, and R. Schlegel The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes J Virol 63 1989 4417 4421
6. A.J. Levine The common mechanisms of transformation by the small DNA tumor viruses: the inactivation of tumor suppressor gene products: p53 Virology 384 2009 285 293
7. M.E. McLaughlin-Drubin, and K. Münger The human papillomavirus E7 oncoprotein Virology 384 2009 335 344
8. M.S. Barbosa, W.C. Vass, D.R. Lowy, and J.T. Schiller In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential J Virol 65 1991 292 298
9. C.L. Halbert, G.W. Demers, and D.A. Galloway The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells J Virol 65 1991 473 478
10. B.A. Werness, A.J. Levine, and P.M. Howley Association of human papillomavirus types 16 and 18 E6 proteins with p53 Science 248 1990 76 79
11. D.V. Heck, C.L. Yee, P.M. Howley, and K. Münger Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses Proc Natl Acad Sci USA 89 1992 4442 4446
12. M.M. Garcia-Alai, L.G. Alonso, and G. dePrat-Gay The N-terminal module of HPV16 E7 is an intrinsically disordered domain that confers conformational and recognition plasticity to the oncoprotein Biochemistry 46 2007 10405 10412
13. E.O. Calçada, I.C. Felli, T. Hosek, and R. Pierattelli The heterogeneous structural behavior of E7 from HPV16 revealed by NMR spectroscopy Chembiochem 14 2013 1876 1882
14. M.G. Noval, M. Gallo, S. Perrone, A.G. Salvay, L.B. Chemes, and G. De Prat-Gay Conformational dissection of a viral intrinsically disordered domain involved in cellular transformation PLoS One 8 2013 e72760
15. O. Ohlenschläger, T. Seiboth, H. Zengerling, L. Briese, A. Marchanka, and R. Ramachandran Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7 Oncogene 25 2006 5953 5959
16. X. Liu, A. Clements, K. Zhao, and R. Marmorstein Structure of the human papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor J Biol Chem 281 2006 578 586
17. K.E. Clemens, R. Brent, J. Gyuris, and K. Münger Dimerization of the human papillomavirus E7 oncoprotein in vivo Virology 214 1995 289 293
18. W. Zwerschke, S. Joswig, and P. Jansen-Durr Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein Oncogene 12 1996 213 220
19. B. Todorovic, P. Massimi, K. Hung, G.S. Shaw, L. Banks, and J.S. Mymryk Systematic analysis of the amino acid residues of human papillomavirus type 16 E7 conserved region 3 involved in dimerization and transformation J Virol 85 2011 10048 10057
20. A. Clements, K. Johnston, J.M. Mazzarelli, R.P. Ricciardi, and R. Marmorstein Oligomerization properties of the viral oncoproteins adenovirus E1A and human papillomavirus E7 and their complexes with the retinoblastoma protein Biochemistry 39 2000 16033 16045
21. N. Dyson, P.M. Howley, K. Münger, and E. Harlow The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product Science 243 1989 934 937
22. K. Münger, B.A. Werness, N. Dyson, W.C. Phelps, E. Harlow, and P.M. Howley Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product EMBO J 8 1989 4099 4105
23. J.O. Lee, A.A. Russo, and N.P. Pavletich Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7 Nature 391 1998 859 865
24. S. Chellappan, V.B. Kraus, B. Kroger, K. Münger, P.M. Howley, and W.C. Phelps Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product Proc Natl Acad Sci USA 89 1992 4549 4553
25. S.N. Boyer, D.E. Wazer, and V. Band E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway Cancer Res 56 1996 4620 4624
26. D.L. Jones, D.A. Thompson, and K. Munger Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis Virology 239 1997 97 107
27. D. Smotkin, and F.O. Wettstein The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein J Virol 61 1987 1686 1689
28. M.S. Barbosa, C. Edmonds, C. Fisher, J.T. Schiller, D.R. Lowy, and K.H. Vousden The region of the HPV E7 oncoprotein homologous to adenovirus E1a and SV40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation EMBO J 9 1990 153 160
29. J.R. Gage, C. Meyers, and F.O. Wettstein The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties J Virol 64 1990 723 730
30. L.B. Chemes, I.E. Sanchez, C. Smal, and G. De Prat-Gay Targeting mechanism of the retinoblastoma tumor suppressor by a prototypical viral oncoprotein FEBS J 277 2010 973 988
31. N.L. Lill, S.R. Grossman, D. Ginsberg, J. DeCaprio, and D.M. Livingston Binding and modulation of p53 by p300/CBP coactivators Nature 387 1997 823 827
32. K. Somasundaram, and W.S. El Deiry Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region Oncogene 14 1997 1047 1057
33. S.M. Frisch, and J.S. Mymryk Adenovirus-5 E1A: paradox and paradigm Nat Rev Mol Cell Biol 3 2002 441 452
34. R.H. Goodman, and S. Smolik CBP/p300 in cell growth, transformation, and development Genes Dev 14 2000 1553 1577
35. H.M. Chan, and N.B. La Thangue p300/CBP proteins: HATs for transcriptional bridges and scaffolds J Cell Sci 114 2001 2363 2373
36. N. Ganguly, and S.P. Parihar Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis J Biosci 34 2009 113 123
37. A. Bernat, N. Avvakumov, J.S. Mymryk, and L. Banks Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300 Oncogene 22 2003 7871 7881
38. D. Fera, and R. Marmorstein Different regions of the HPV-E7 and Ad-E1A viral oncoproteins bind competitively but through distinct mechanisms to the CH1 transactivation domain of p300 Biochemistry 51 2012 9524 9534
39. H.G. Wang, E. Moran, and P. Yaciuk E1A promotes association between p300 and pRB in multimeric complexes required for normal biological activity J Virol 69 1995 7917 7924
40. J. Zhang, O. Yamada, K. Kawagishi, H. Araki, S. Yamaoka, and T. Hattori Human T-cell leukemia virus type 1 Tax modulates interferon-α signal transduction through competitive usage of the coactivator CBP/p300 Virology 379 2008 306 313
41. J.M. Wojciak, M.A. Martinez-Yamout, H.J. Dyson, and P.E. Wright Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domains EMBO J 28 2009 948 958
42. C.W. Lee, J.C. Ferreon, A.C. Ferreon, M. Arai, and P.E. Wright Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation Proc Natl Acad Sci USA 107 2010 19290 19295
43. M. Arai, J.C. Ferreon, and P.E. Wright Quantitative analysis of multisite protein-ligand interactions by NMR: binding of intrinsically disordered p53 transactivation subdomains with the TAZ2 domain of CBP J Am Chem Soc 134 2012 3792 3803
44. R.N. De Guzman, H.Y. Liu, M. Martinez-Yamout, H.J. Dyson, and P.E. Wright Solution structure of the TAZ2 (CH3) domain of the transcriptional adaptor protein CBP J Mol Biol 303 2000 243 253
45. J.C. Ferreon, M.A. Martinez-Yamout, H.J. Dyson, and P.E. Wright Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein Proc Natl Acad Sci USA 106 2009 13260 13265
46. J. Yao, H.J. Dyson, and P.E. Wright Chemical shift dispersion and secondary structure prediction in unfolded and partly folded proteins FEBS Lett 419 1997 285 289
47. M. Singh, M. Krajewski, A. Mikolajka, and T.A. Holak Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences J Biol Chem 280 2005 37868 37876
48. Q. Deng, Y. Li, D. Tedesco, R. Liao, G. Fuhrmann, and P. Sun The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins Cancer Res 65 2005 8298 8307
49. A.M. Helt, and D.A. Galloway Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes J Virol 75 2001 6737 6747
50. H.M. Chan, M. Krstic-Demonacos, L. Smith, C. Demonacos, and N.B. La Thangue Acetylation control of the retinoblastoma tumour-suppressor protein Nat Cell Biol 3 2001 667 674
51. D.X. Nguyen, L.A. Baglia, S.M. Huang, C.M. Baker, and D.J. McCance Acetylation regulates the differentiation-specific functions of the retinoblastoma protein EMBO J 23 2004 1609 1618
52. L.H. Kasper, S. Lerach, J. Wang, S. Wu, T. Jeevan, and P.K. Brindle CBP/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation EMBO J 29 2010 3660 3672
53. L.H. Kasper, M.C. Thomas, G.P. Zambetti, and P.K. Brindle Double null cells reveal that CBP and p300 are dispensable for p53 targets p21 and Mdm2 but variably required for target genes of other signaling pathways Cell Cycle 10 2011 212 221
54. M.O. Hottiger, and G.J. Nabel Viral replication and the coactivators p300 and CBP Trends Microbiol 8 2000 560 565
55. Z. Arany, D. Newsome, E. Oldread, D.M. Livingston, and R. Eckner A family of transcriptional adaptor proteins targeted by the E1A oncoprotein Nature 374 1995 81 84
56. R. Eckner, M.E. Ewen, D. Newsome, M. Gerdes, J.A. DeCaprio, and J.B. Lawrence Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor Genes Dev 8 1994 869 884
57. R.N. De Guzman, J.M. Wojciak, M.A. Martinez-Yamout, H.J. Dyson, and P.E. Wright CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding Biochemistry 44 2005 490 497
58. T. Matt, M.A. Martinez-Yamout, H.J. Dyson, and P.E. Wright The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2 Biochem J 381 2004 685 691
59. W.-M. Chien, J.N. Parker, D.-C. Schmidt-Grimminger, T.R. Broker, and L.T. Chow Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry Cell Growth Differ 11 2000 425 435
60. J.M. Firzlaff, B. Luscher, and R.N. Eisenman Negative charge at the casein kinase II phosphorylation site is important for transformation but not for Rb protein binding by the E7 protein of human papillomavirus type 16 Proc Natl Acad Sci USA 88 1991 5187 5191
61. H. Feng, L.M.M. Jenkins, S.R. Durell, R. Hayashi, S.J. Mazur, and S. Cherry Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation Structure 17 2009 202 210
62. P. Bhaumik, J. Davis, J.E. Tropea, S. Cherry, P.F. Johnson, and M. Miller Structural insights into interactions of C/EBP transcriptional activators with the Taz2 domain of p300 Acta Crystallogr Sect D Biol Crystallogr 70 2014 1914 1921
63. J.A. Howe, J.S. Mymryk, C. Egan, P.E. Branton, and S.T. Bayley Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis Proc Natl Acad Sci USA 87 1990 5883 5887
64. R. Eckner, J.W. Ludlow, N.L. Lill, E. Oldread, Z. Arany, and N. Modjtahedi Association of p300 and CBP with simian virus 40 large T antigen Mol Cell Biol 16 1996 3454 3464
65. M.L. Avantaggiati, V. Ogryzko, K. Gardner, A. Giordano, A. Levine, and K. Kelly Recruitment of p300/CBP in p53-dependent signal pathways Cell 89 1997 1175 1184
66. W. Gu, X.L. Shi, and R.G. Roeder Synergistic activation of transcription by CBP and p53 Nature 387 1997 819 823
67. A.C. Ferreon, J.C. Ferreon, P.E. Wright, and A.A. Deniz Modulation of allostery by protein intrinsic disorder Nature 498 2013 390 394
68. P. Massimi, and L. Banks Repression of p53 transcriptional activity by the HPV E7 proteins Virology 227 1997 255 259
69. A. Eichten, M. Westfall, J.A. Pietenpol, and K. Münger Stabilization and functional impairment of the tumor suppressor p53 by the human papillomavirus type 16 E7 oncoprotein Virology 295 2002 74 85
70. W.C. Phelps, K. Münger, C.L. Yee, J.A. Barnes, and P.M. Howley Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein J Virol 66 1992 2418 2427
71. E.W. Wu, K.E. Clemens, D.V. Heck, and K. Münger The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein J Virol 67 1993 2402 2407
72. A.R. Fattaey, E. Harlow, and K. Helin Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes Mol Cell Biol 13 1993 7267 7277
73. F. Schwarze, J. Meraner, M. Lechner, A. Loidl, T. Stasyk, and A. Laich Cell cycle-dependent acetylation of Rb2/p130 in NIH3T3 cells Oncogene 29 2010 5755 5760
74. P. Massimi, and L. Banks Differential phosphorylation of the HPV-16 E7 oncoprotein during the cell cycle Virology 276 2000 388 394
75. B. Zhang, W. Chen, and A. Roman The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation Proc Natl Acad Sci USA 103 2006 437 442
76. P. Sdek, H. Ying, D.L.F. Chang, W. Qiu, H. Zheng, and R. Touitou MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein Mol Cell 20 2005 699 708
77. C. Uchida, S. Miwa, K. Kitagawa, T. Hattori, T. Isobe, and S. Otani Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation EMBO J 24 2005 160 169
78. S.M. Rubin Deciphering the retinoblastoma protein phosphorylation code Trends Biochem Sci 38 2013 12 19
79. J.R. Burke, G.L. Hura, and S.M. Rubin Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control Genes Dev 26 2012 1156 1166
80. S.M. Rubin, A.L. Gall, N. Zheng, and N.P. Pavletich Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release Cell 123 2005 1093 1106
81. K. Sugase, M.A. Landes, P.E. Wright, and M. Martinez-Yamout Overexpression of post-translationally modified peptides in Escherichia coli by co-expression with modifying enzymes Protein Expression Purif 57 2008 108 115
82. G.B. Legge, M.A. Martinez-Yamout, D.M. Hambly, T. Trinh, B.M. Lee, and H.J. Dyson ZZ domain of CBP: an unusual zinc finger fold in a protein interaction module J Mol Biol 343 2004 1081 1093
83. F. Delaglio, S. Grzesiek, G.W. Vuister, Z. Guang, J. Pfeifer, and A. Bax NMRPipe: a multidimensional spectral processing system based on UNIX pipes J Biomol NMR 6 1995 277 293
84. B.A. Johnson, and R.A. Blevins NMRView: a computer program for the visualization and analysis of NMR data J Biomol NMR 4 1994 603 614
85. T.D. Goddard, and D.G. Kneller SPARKY 3 2006 University of California San Francisco
86. S. Grzesiek, and A. Bax Correlating backbone amide and side chain resonances in larger proteins by multiple relayed triple resonance NMR J Am Chem Soc 114 1992 6291 6293
87. S. Grzesiek, and A. Bax Improved 3D triple-resonance NMR techniques applied to a 31 kDa protein J Magn Reson 96 1992 432 440
88. M. Wittekind, and L. Mueller HNCACB, a high-sensitivity 3D NMR experiment to correlate amide-proton and nitrogen resonances with the alpha- and beta-carbon resonances in proteins J Magn Reson 101 1993 201 205
89. 13C-enriched proteins J Magn Reson 88 1990 425 431
90. P. Sun, P. Dong, K. Dai, G.J. Hannon, and D. Beach p53-independent role of MDM2 in TGF-beta1 resistance Science 282 1998 2270 2272